These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 96833)

  • 1. Concomitant secretion by transformed SVWI38-VA13-2RA cells of plasminogen activator(s) and substance (s) which prevent their detection.
    Roblin RO; Young PL; Bell TE
    Biochem Biophys Res Commun; 1978 May; 82(1):165-72. PubMed ID: 96833
    [No Abstract]   [Full Text] [Related]  

  • 2. New assay for the plasminogen activator activity of transformed cells.
    Mangel WF; Livingston DC; Brocklehurst JR; Liu HY; Peltz GA; Cannon JF; Leytus SP; Wehrly JA; Salter BL; Mosher JL
    Cold Spring Harb Symp Quant Biol; 1980; 44 Pt 1,():669-80. PubMed ID: 6448727
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasminogen activator activity of isolated cardiac muscle microvessel endothelial cells.
    Shepro D; Li S; Hechtman HB
    Thromb Res; 1980 Jun; 18(5):609-16. PubMed ID: 6774440
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of a plasminogen activator from oncogenic virus-transformed mouse cells by rabbit antibodies against the enzyme.
    Danø K; Nielsen LS; Møller V; Engelhart M
    Biochim Biophys Acta; 1980 Jun; 630(1):146-51. PubMed ID: 6248125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
    Félez J; Rueda F
    Sangre (Barc); 1985; 30(4-C):779-86. PubMed ID: 3937250
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on interactions between plasminogen activator-containing fluids and avain and murine lymphocytes.
    Wainberg MA; Cohen SD
    Dev Comp Immunol; 1981; 5(4):649-60. PubMed ID: 6274714
    [No Abstract]   [Full Text] [Related]  

  • 7. [Liberation of plasminogen activators].
    Klöcking HP; Bock G; Drawert J; Hinsenbrock KP; Kaiser B; Sedlarik U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):404-24. PubMed ID: 63428
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasminogen activator and the membrane of transformed cells.
    Quigley JP; Goldfarb RH; Scheiner C; O'Donnell-Tormey J; Yeo TK
    Prog Clin Biol Res; 1980; 41():773-96. PubMed ID: 6256777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood platelet plasminogen activator inhibitor: two different pools of endothelial cell type plasminogen activator inhibitor in human blood.
    Sprengers ED; Akkerman JW; Jansen BG
    Thromb Haemost; 1986 Jun; 55(3):325-9. PubMed ID: 3092389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of dexamethasone inhibition of plasminogen activator in rat hepatoma cells.
    Seifert SC; Gelehrter TD
    Proc Natl Acad Sci U S A; 1978 Dec; 75(12):6130-3. PubMed ID: 104300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone regulation of plasminogen activator in embryonic and tumor-derived human cells.
    Roblin R; Young PL
    Cancer Res; 1980 Aug; 40(8 Pt 1):2706-13. PubMed ID: 6771003
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fibrinolysis and disseminated intravascular coagulation].
    Ikematsu S
    Rinsho Byori; 1985 Jun; Spec No 63():27-36. PubMed ID: 2931536
    [No Abstract]   [Full Text] [Related]  

  • 13. [Short-acting fibrinolysis in the etiology of venous thrombosis].
    Petäjä J; Myllylä G; Rasi V; Vahtera E
    Duodecim; 1988; 104(5):317-24. PubMed ID: 3139389
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms of inhibition of tissue-type plasminogen activator in blood.
    Collen D
    Thromb Haemost; 1983 Oct; 50(3):678. PubMed ID: 6417816
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasminogen activator release from cultured murine mast cells.
    Bartholomew JS; Woolley DE
    Biochem Biophys Res Commun; 1988 Jun; 153(2):540-4. PubMed ID: 3132912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the plasminogen activator activity of a transformed cell line by cell density.
    Liu HY; Peltz SW; Mangel WF
    Mol Cell Biol; 1982 Nov; 2(11):1410-6. PubMed ID: 6819454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The determination of antiactivator; especially inhibitors against the activator-induced fibrin clot lysis (author's transl)].
    Matsuda M; Yoshida N; Moroi M; Aoki N
    Rinsho Byori; 1976 Apr; 24(4):325-8. PubMed ID: 819683
    [No Abstract]   [Full Text] [Related]  

  • 18. Type 1 plasminogen activator inhibitor and its potential influence on thrombolytic therapy.
    Loskutoff DJ
    Semin Thromb Hemost; 1988 Jan; 14(1):100-9. PubMed ID: 3127883
    [No Abstract]   [Full Text] [Related]  

  • 19. Interferon inhibits the release of plasminogen activator from SV3T3 cells.
    Schroder EW; Chou IN; Jaken S; Black PH
    Nature; 1978 Dec 21-28; 276(5690):828-9. PubMed ID: 214713
    [No Abstract]   [Full Text] [Related]  

  • 20. [Molecular markers of hemostatic mechanisms--interaction of plasminogen activator and its inhibitor].
    Sakata Y
    Rinsho Byori; 1989 Mar; 37(3):256-60. PubMed ID: 2787424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.